Peng et al. reported that piR-55490 inhibits the activation of the Akt/mTOR pathway in lung cancer cells by binding to the 3'UTR of mTOR mRNA and inducing its degradation, thereby inhibiting cell proliferation [80]. The gene discussed is MTOR; the disease is lung carcinoma.